The growing demand for precise immunological investigation and therapeutic design has spurred significant advances in recombinant growth factor production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently manufactured using various expression methods, including microbial hosts, animal cell lines, and insect e